Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 11 (RPL36AP11)

Target
RPL36AP11
Molecular classification
Other
01

Overview

Ribosomal protein L36a pseudogene 11 (RPL36AP11) is a processed pseudogene in the human genome that is related in sequence to the functional ribosomal protein L36a gene (RPL36A). The RPL36AP11 locus does not encode a functional protein and is categorized as a pseudogene, not a protein-coding gene, enzyme, receptor, or other canonical drug target. Like many ribosomal protein genes, clusters of related pseudogenes, including RPL36AP11, are scattered throughout the genome and have no known biological function, disease relevance, or role as therapeutic targets[7]. Key context: - RPL36AP11 differs fundamentally from its functional paralogs RPL36A and RPL36AL, both of which encode ribosomal proteins involved in protein synthesis and with reported links to diseases such as Diamond-Blackfan anemia and certain cancers[1][2][3][5]. - Pseudogenes like RPL36AP11 lack coding potential; some can regulate gene expression but there is no evidence this is the case for RPL36AP11 specifically. - RPL36AP11 is thus not considered a therapeutic target, biomarker, enzyme, or functional biological entity[7]. Summary: RPL36AP11 is a nonfunctional processed pseudogene with no confirmed protein product, biological role, disease implication, or utility as a drug target. Its designation as a gene "target" is likely incorrect for scientific and therapeutic purposes[7].

Other names
RPL36A_2_73RPL36AP11

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 11 (RPL36AP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 11 (RPL36AP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call